The combination of methyl eugenol (60 μM) with myricetin (60 μM) synergistically enhanced the cancer cell growth inhibition of cisplatin (1 μM) by inducing strong apoptosis, arresting cells in the G0/G1 phase of the cell cycle, enhancing ΔΨm, and upregulating caspase-3 activity in the HeLa immortal cervical cell lines [46]. This evidence concerns the gene CASP3 and cancer.